熱門資訊> 正文
艾伯维与Iambic Therapeutics达成多年人工智能药物发现协议
2026-09-21 20:09
- 艾伯維公司(ABBV) 0
- 摩根士丹利(MS) 0
- 富國銀行(WFC) 0
- AbbVie (ABBV) and Iambic Therapeutics have entered a multi-year collaboration to discover and develop small-molecule therapies for immunology, neuroscience, and oncology using Iambic's AI discovery platform.
- The companies will leverage Iambic's AI platform to improve the efficiency and success of identifying promising new drug candidates.
- Under the terms of the collaboration, Iambic will receive an upfront payment and is eligible to receive success-based milestone payments and tiered royalties on net sales from products generated from the collaboration.
- The collaboration targets both first-in-class and best-in-class small molecule drug candidates.
- ABBV is down about 1% premarket.
More on AbbVie
- AbbVie Inc. (ABBV) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
- AbbVie Inc. (ABBV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
- AbbVie: Shares Defy Sell-Side Downgrades, And That's Bullish (Technical Analysis)
- Trump announces MFN pricing for Medicaid in all states
- AbbVie succeeds in late-stage trial for multiple myeloma drug
推薦文章
美股前瞻 | 霍爾木茲海峽或7天內重開！國際油價齊挫，三大期指轉升；美聯儲「二把手」今夜發言；阿里雲棲大會加碼AI基建及自研芯片
Meta點燃半導體、CPU「超級行情」！英特爾年內勁升超230%，AI硬件還有哪些標的獲看好？
華盛早報 | 兩大利好引爆芯片股！英特爾大漲12%，AMD市值破萬億美元；Muse智能體助推Meta飆升11%；阿里雲棲大會今日開幕
美股前瞻 | 中美高層會談釋放積極信號！納指期貨升逾1%；比特幣再度站上8.5萬美元；英特爾盤前升逾5%，佈局先進封裝劍指光通信賽道
新股申購 | 四隻新股今起招股！PCB龍頭景旺電子、直驅機器人公司本末科技、羅博特科、彤程新材在列
港股異動 | 創新葯概念集體走高，英派藥業-B飆漲逾27%，榮昌生物、康方生物、信達生物漲逾6%，藥明生物漲逾5%
華盛早報 | 中美經貿磋商正在紐約進行！特朗普引爆資源股！GLND夜盤飆升119%；景旺電子等四隻新股今起招股
港股周報 | 加息落地！科技股企穩反彈，恆生科指漲近2%；利潤率比肩戴爾？聯想周漲20%再創新高
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
